Monthly Archives: August 2014

NICE and Roche at loggerheads (again)

  NICE has today (8th August 2014) announced that it cannot recommend Roche’s latest breast cancer drug, Kadcyla (a combination of trastuzumab and emtansine) for routine use on the NHS because it is too expensive and hence not cost-effective.  The draft ‘no’ was actually published in May, but there has been a press release issued today …read more

Posted in Blog, News | Tagged , | Group: | Comments closed

Does pay for performance work or doesn’t it?

Martin Roland discusses the effects of pay for performance, following on from our study published in the New England Journal of Medicine this week.

Posted in Blog | Tagged , , , | Group: | Comments closed

Medicalising life

Medicines have been getting into the mainstream news quite a lot in recent times. A couple of days ago saw the publication in Annals of Oncology of a review of the evidence for a protective effect of aspirin in reducing cancer in the general population. The role of aspirin in cardiovascular disease prevention is well …read more

Posted in Blog | Tagged , , , , | Group: | Comments closed
  • The Cambridge Centre for Health Services Research (CCHSR) is a thriving collaboration between the University of Cambridge and RAND Europe. We aim to inform health policy and practice by conducting research and evaluation studies of organisation and delivery of healthcare, including safety, effectiveness, efficiency and patient experience.